E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers N > Headlines for Nectar Lifesciences Ltd. > News item
Published on 11/11/2005 in the Prospect News Biotech Daily, Prospect News Convertibles Daily and Prospect News Emerging Markets Daily.

India's Nectar Lifesciences may sell up to $100 million convertibles, stock

New York, Nov. 11 - Nectar Lifesciences Ltd. said it may sell up to $100 million of foreign currency convertible bonds, Global Depositary Receipts, American Depositary Receipts or other securities.

The proposed issuance will be considered by Nectar's board at a meeting on Nov. 18.

Nectar is a Chandigarh, India-based maker of active pharmaceutical ingredients.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.